PHARMANOVA AS

8470 BØ I VESTERÅLEN

Finances

Share Ownership

Return on Equity

−6,51 %

Current Ratio

3,52

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	2 589 000	3 684 000	3 037 000	3 599 000
Net Income	−110 000	−477 000	902 000	1 577 000
Total Assets	2 298 000	2 293 000	3 671 000	5 211 000
Total Equity	1 691 000	1 800 000	2 277 000	2 075 000

Income (NOK)	2022	2021	2020	2019
Revenue	2 589 000	3 684 000	3 037 000	3 599 000
Expenditure	2 736 000	4 145 000	1 887 000	1 588 000
Operating Profit	−148 000	−460 000	1 151 000	2 011 000
Financial Income	36 000	1 000	5 000	11 000
Financial Costs	0	17 000	0	0
Financial Balance	36 000	−16 000	5 000	11 000
Earnings Before Tax	−112 000	−475 000	1 156 000	2 022 000
Tax	−2 000	1 000	254 000	445 000
Net Income	−110 000	−477 000	902 000	1 577 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	160 000	0	15 000	1 618 000
Total Current Assets	2 138 000	2 293 000	3 656 000	3 593 000
Total Assets	2 298 000	2 293 000	3 671 000	5 211 000
Total Retained Equity	1 591 000	1 700 000	2 177 000	1 975 000
Total Equity	1 691 000	1 800 000	2 277 000	2 075 000
Total Long-Term Debt	0	2 000	1 000	1 000
Total Current Debt	608 000	491 000	1 393 000	3 135 000
Total Equity and Debt	2 298 000	2 293 000	3 671 000	5 211 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	2 585 000	3 684 000	3 037 000	3 599 000
Other Income	4 000	0	0	0
Revenue	2 589 000	3 684 000	3 037 000	3 599 000
Cost of Goods Sold	1 703 000	371 000	502 000	770 000
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	2 736 000	4 145 000	1 887 000	1 588 000
Operating Profit	−148 000	−460 000	1 151 000	2 011 000
Financial Income	36 000	1 000	5 000	11 000
Financial Costs	0	17 000	0	0
Financial Balance	36 000	−16 000	5 000	11 000
Dividends	0	0	700 000	1 989 000
Net Income	−110 000	−477 000	902 000	1 577 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	160 000	0	15 000	1 618 000
Total Fixed Assets	160 000	0	15 000	1 618 000
Stock	229 000	553 000	924 000	150 000
Total Investments	0	15 000	0	0
Cash, Bank	386 000	1 174 000	1 042 000	3 210 000
Total Current Assets	2 138 000	2 293 000	3 656 000	3 593 000
Total Assets	2 298 000	2 293 000	3 671 000	5 211 000
Total Equity	1 691 000	1 800 000	2 277 000	2 075 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	2 000	1 000	1 000
Creditors	63 000	125 000	132 000	647 000
Unpaid Taxes	16 000	42 000	9 000	38 000
Dividends	0	0	700 000	1 989 000
Other Current Debt	529 000	324 000	998 000	2 005 000
Total Current Debt	608 000	491 000	1 393 000	3 135 000
Total Equity and Debt	2 298 000	2 293 000	3 671 000	5 211 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−6,51 %	−26,5 %	39,61 %	76 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−5,72 %	−12,49 %	37,9 %	55,88 %
Current Ratio	3,52	4,67	2,62	1,15
Quick Ratio	5,64	−36,98	7,8	1,2
Equity Ratio	0,74	0,78	0,62	0,4
Gross Profit Margin	34,22 %	89,93 %	83,47 %	78,61 %